Zobrazeno 1 - 10
of 210
pro vyhledávání: '"López-Saura P"'
Autor:
Casanova-Orta Mayté, Ramírez-Nuñez Omar, Valenzuela-Silva Carmen M, Cabrera-Gómez José A, Martínez-Sánchez Gregorio, Cervantes-Llanos Majel, Pentón-Rol Giselle, Robinson-Agramonte María A, Lopategui-Cabezas Ileana, López-Saura Pedro A
Publikováno v:
Journal of Inflammation, Vol 6, Iss 1, p 18 (2009)
Abstract Background Neuromyelitis optica is a central nervous system demyelinating and inflammatory syndrome. The objective of this study is to identify cytokines related to the cellular immune response as well as blood brain barrier integrity and ox
Externí odkaz:
https://doaj.org/article/8af201695f7c433da15860e4007b3acf
Autor:
Alonso Daniel F, Gómez Roberto, Ramos Thelvia, Castillo Dagnelia, Díaz Alina, González Carlos A, Valenzuela Carmen, Baladrón Idania, Santana Agueda, Solares Ana M, Herrera Luis, Sigman Hugo, Perea Silvio E, Acevedo Boris E, López-Saura Pedro
Publikováno v:
BMC Cancer, Vol 9, Iss 1, p 146 (2009)
Abstract Background Cervical cancer is now considered the second leading cause of death among women worldwide, and its incidence has reached alarming levels, especially in developing countries. Similarly, high grade squamous intraepithelial lesion (H
Externí odkaz:
https://doaj.org/article/48467441653a43dda6c9f01197440a48
Autor:
Sánchez-de la Osa Reinaldo B, Fernández-Olivera Norma, Bello-Rivero Iraldo, Ramos-Gómez Thelvia I, Jiménez-Madrigal Gaspar, Valenzuela-Silva Carmen M, Valdés-Quintana Magalys, Santos-Herrera Yamilet, García-García Idrian, Milanés-Virelles María T, Rodríguez-Acosta Carmen, González-Méndez Lidia, Martínez-Sánchez Gregorio, López-Saura Pedro A
Publikováno v:
BMC Infectious Diseases, Vol 8, Iss 1, p 17 (2008)
Abstract Background High antibiotic resistance is described in atypical Mycobacteriosis, mainly by Mycobacterium avium complex (MAC). Methods A randomized, double-blind, placebo-controlled clinical trial was carried out in two hospitals to evaluate t
Externí odkaz:
https://doaj.org/article/311812dce85646d08c12fb74dbaef5e1
Autor:
Javier-González Luís, Fernández-Batista Osmani, Pentón-Rol Giselle, Blanco-Garcés Elizabeth, Torrez-Ruiz Yeny, Bello-Rivero Iraldo, Gerónimo-Perez Haydee, López-Saura Pedro
Publikováno v:
BMC Biotechnology, Vol 6, Iss 1, p 25 (2006)
Abstract Background TH1 immune response antagonism is a desirable approach to mitigate some autoimmune and inflammatory reactions during the course of several diseases where IL-2 and IFN-γ are two central players. Therefore, the neutralization of bo
Externí odkaz:
https://doaj.org/article/5c38b2ab99164204a354a184b43642ef
Autor:
Ávila-Albuerne Yisel, Casanova-Kutsareva Yuri, Lagarde-Ampudia Marcia, Hernández-Montero Tairí, Valenzuela-Silva Carmen M, Porrero-Martín Pedro J, García-García Idrian, Casanova-González Martha, Pérez-Oliva Jorge F, Vargas-Batista Alicia, Bobillo-López Hailen, Herrera-Valdés Raúl, López-Saura Pedro A
Publikováno v:
BMC Nephrology, Vol 6, Iss 1, p 5 (2005)
Abstract Background Recombinant human erythropoietin (EPO) is used for the treatment of last stage renal anemia. A new EPO preparation was obtained in Cuba in order to make this treatment fully nationally available. The aim of this study was to compa
Externí odkaz:
https://doaj.org/article/b3b92826ecd748e9b08ecde7460c61b8
Autor:
Carbonell Dalia, Milanés-Virelles María T, Valdés-Quintana Magalys, Fernández-Olivera Norma, García-García Idrian, Suárez-Méndez Roberto, Machado-Molina Delfina, Valenzuela-Silva Carmen M, López-Saura Pedro A
Publikováno v:
BMC Infectious Diseases, Vol 4, Iss 1, p 44 (2004)
Abstract Background Tuberculosis (TB) is increasing in the world and drug-resistant (DR) disease beckons new treatments. Methods To evaluate the action of interferon (IFN) gamma as immunoadjuvant to chemotherapy on pulmonary DR-TB patients, a pilot,
Externí odkaz:
https://doaj.org/article/09f5ba2308314e55abded23bb86cd762
Autor:
Hugo Nodarse-Cuní, Pedro A López-Saura
Publikováno v:
Biotecnología Aplicada, Vol 34, Iss 1, Pp 1211-1217 (2017)
Externí odkaz:
https://doaj.org/article/30abe79e9ff84927ae99c4e549af8ad1
Autor:
Rolando Páez-Meireles, Fidel R Castro-Odio, José Ramón-Hernández, Dinorah Torres, Carelia Cosme, Hugo Nodarse, Oscar Cruz, Ernesto Urrutia, Carmen Chuay, Jorge Luis Vega, Yolegnys Peña, Luis Herrera-Martínez, Matilde López, Pedro López-Saura, Idrian García, Odaly Amarante, Eduardo Martínez-Díaz, Iván Sosa, Joel Ferrero, Lourdes Costa, Eduardo Fernández, Yanet Terrero, Sheila Padrón, Lázara Muñoz, Inalvis Herrera, Dania Bacardí, Yadira Hidalgo, Isabel Apezteguía, Vivian Saez, Carlos Peniche
Publikováno v:
Biotecnología Aplicada, Vol 32, Iss 3, Pp 3521-3523 (2015)
Externí odkaz:
https://doaj.org/article/cf6467f285794d27a05747f98bc47aeb
Autor:
Enrique Arús Soler, Luis Rivera Reimón, Anayda Fernández Naranjo, Mirtha Infante Velázquez, Rafael Jorge Díaz, Grisel Soto Argüelles, Pedro López Saura, Bienvenido Gra Oramas
Publikováno v:
Revista Cubana de Medicina, Vol 39, Iss 1, Pp 12-20 (2000)
Se realizó un ensayo controlado aleatorizado multicentro constituido por 35 pacientes con diagnóstico de hepatitis crónica C, 19 correspondían al grupo tratado con interferón (grupo I) y 16 conformaron el grupo control. Se utilizó interferón a
Externí odkaz:
https://doaj.org/article/3f339a283c774be5943d6ca76489898b
Autor:
Enrique Arús Soler, Luis Rivera Reimón, Mirtha Infante Velázquez, Marlen Pérez Lorenzo, Grisel Soto Argüelles, Bievenido Gra Oramas, Guillermo Padrón González, Pedro López Saura
Publikováno v:
Revista Cubana de Medicina, Vol 39, Iss 1, Pp 21-29 (2000)
Se llevó a cabo un ensayo clínico con el objetivo de evaluar la eficacia y la seguridad del interferón en un grupo de 13 pacientes con hepatitis aguda por virus C. Se realizó el diagnóstico siguiendo criterios bioquímicos (alaninoaminotransfera
Externí odkaz:
https://doaj.org/article/1bad6af311524b2d80508e28c87174b2